Share on LinkedInShare on LinkedIn

ARTICLE · 06 NOVEMBER 2020

CSA Highlight Common Deficiencies In COVID-19 Disclosure

Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
Contributor
Blake, Cassels & Graydon LLP

Blake, Cassels & Graydon LLP

As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...

View firm profile
Explore more from Blake, Cassels & Graydon LLP

On October 29, 2020, the Canadian Securities Administrators (CSA) released CSA Staff Notice 51-361 – Continuous Disclosure Review Program Activities...

CanadaCoronavirus (COVID-19)

On October 29, 2020, the Canadian Securities Administrators (CSA) released CSA Staff Notice 51-361 – Continuous Disclosure Review Program Activities for the fiscal years ended March 31, 2020 and March 31, 2019 (Notice). The Notice summarizes the results of the CSA's continuous disclosure review programs for the past two years and also includes information and guidance in respect of areas where the CSA have identified common deficiencies, with a particular focus on disclosures concerning the impact of COVID-19 on Canadian public companies. This guidance is particularly helpful for Canadian public companies crafting descriptions of the impact of COVID-19 in their continuous disclosure documents during these challenging times.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

For permission to reprint articles, please contact the [email protected] Marketing Department.

© 2026 Blake, Cassels & Graydon LLP.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from